Despite OpenAI's bold claims of widespread improvements, GPT-5.2 feels largely the same as the model it replaces. Google, ...
“Surprise heirs like Thomas are popping up because of DNA test kits,” according to the Wall Street Journal article. While ...
England’s managing director of men’s cricket Rob Key says he will investigate the drinking habits of the England team following reports that their mid-Ashes beach break involved over-indulging of ...
Instacart is ending a program where customers saw different prices for the same product ordered at the same time from the ...
The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.
Adults with ADHD who understand and apply their personal strengths experience better well-being and fewer mental health difficulties.
Medical Device Network on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
Administering an exam used to be straightforward: All a college professor needed was an open room and a stack of blue books. At many American universities, this is no longer true. Professors now ...
ATLANTA — Several lots of an ADHD medication has been recalled over concerns revealed by testing. Sun Pharmaceutical Industries Inc. has initiated a voluntary recall of Lisdexamfetamine Dimesylate ...
WASHINGTON — Several lots of a prescription ADHD medication have been recalled due to some failed lab tests, according to FDA Enforcement Reports. The nationwide recall covers several batches of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback